BWS Dialogues

Brandwidth Solutions

BWS Dialogues is a podcast from Brandwidth Solutions that explores the business topics and challenges our clients face, the opportunities for growth, and how to deploy the art and science of marketing to drive business success. Each episode features conversations with top leaders and problem solvers who share real-world insights, strategies, and best practices. Whether you're navigating complexity or bridging the gap between strategy and results, BWS Dialogues delivers practical perspectives to navigate critical topics and tackle the challenges that matter the most.

Episodes

  1. Episode 6: Video for B2B Life Sciences Marketing—Advice from Robert Weiss

    FEB 2

    Episode 6: Video for B2B Life Sciences Marketing—Advice from Robert Weiss

    Video is a powerful marketing tool. Yet B2B marketers often struggle to develop a clear strategy for using video. The tactics can feel daunting too. What types of videos should we make? What types of topics best lend themselves to video? What if our staff is nervous about being in front of the camera? How do we get the best ROI? To address these questions, we sat down with Robert Weiss, the executive producer and director of MultiVision Digital, a video production and video marketing company. Robert has produced over 1700 marketing videos that have helped clients increase sales, create lead generation, improve SEO rankings, and increase both awareness and client loyalty. We discussed: · What video does better than other marketing tools · The value of video for building the know-like-and-trust factor · What makes a marketing video effective · What types of content are best, and most underutilized, for B2B marketing videos · Why you shouldn’t start by thinking about what your video will show · How filmed and animated videos fit into a broader strategy · His advice about making videos with AI · Why you shouldn’t think “video,” but instead think “video project” · How to get the best ROI from B2B marketing videos Listen in, as Robert draws on his decades of experience to offer concrete advice. Learn more & connect! · Visit brandwidthsolutions.com for more information about our services! · Connect with our guest, Robert Weiss: LinkedIn · Learn more about MultiVision Digital, including how they create Videos for Manufacturing · Learn more about video budgets with the blue tree video · Connect with our podcast host, Laura Bush: LinkedIn

    37 min
  2. Episode 5: AI in Pharma Manufacturing — Observations from Pat Day

    JAN 5

    Episode 5: AI in Pharma Manufacturing — Observations from Pat Day

    Pharmaceutical manufacturing, quality, and supply chain management can all benefit from the wise application of artificial intelligence (AI). But what approach should pharma manufacturers take to harnessing AI in these areas? And what are the risks? To explore these questions, we sat down with Pat Day, a principal consultant at Lachman Consultants. Following more than 25 years working inside the pharmaceutical industry, Pat now serves as a consultant, focusing on areas such as risk management, data integrity and data governance, and supply chain logistics — and now, AI. We discussed: Where AI can offer the most immediate benefits in pharmaceutical manufacturing and qualityThe common mistake corporate leaders make in AI initiatives — and the risks that result (hint: protect your institutional knowledge)The value of AI “sprints”Why companies should approach AI projects as experiments — that are allowed to failWhat the regulators are saying so far, and why industry shouldn’t wait for agency “permission”The opportunity to use AI to develop data skills in quality and regulatory teamsGiven all he has seen, Pat offers his advice for rethinking ROI for AI in pharma manufacturing and quality and suggests best practices for thoughtful implementation. Learn more & connect! Visit brandwidthsolutions.com for more information about our services!Connect with our guest, Pat Day: LinkedInLearn more about Lachman ConsultantsConnect with our podcast host, Laura Bush: LinkedIn

    57 min
  3. Episode 3: Connection, Credibility, and Trust - User Experience Advice from Stephanie Fox

    11/26/2025

    Episode 3: Connection, Credibility, and Trust - User Experience Advice from Stephanie Fox

    For B2B companies serving customers in the life sciences — in areas such as bio/pharmaceutical CDMO services, diagnostics, life sciences instrumentation, and laboratory software — creating and maintaining an engaging website is a challenging undertaking. Potential customers are smart and highly educated, and need a sufficient level of detail to inform their buyer’s journey. But they are also busy, impatient, and don’t have time to waste. So how can life sciences companies optimize their websites and web content to attract and retain the interest of their potential buyers? To explore the nuances of this question, we sat down with Stephanie Fox. Stephanie Fox has been a website user experience (UX) practitioner for more than 25 years, and she recently published a book on this topic, called, Would You Date Your Website? We discussed: The must-haves of user experience (UX) for technical B2B online spaces What “scannable” content looks like for scientific and technical audiences today How content and webpage design impact trust The most overlooked aspects of user experience (UX) How artificial intelligence (AI) is affecting user experience Stephanie offers advice and wisdom, based on her decades of expertise, for ensuring optimal user experience on any B2B website for the life sciences industry. Learn more & connect! Visit brandwidthsolutions.com for more information about our services! Connect with our guest, Stephanie Fox, on LinkedIn Check out Stephanie’s book: Would You Date Your Website? Connect with our podcast host, Meg Sizemore: LinkedIn

    22 min
  4. Episode 1: API Stockpiling and U.S. Pharma Supply - Insights from PBOA’s Gil Roth

    09/25/2025

    Episode 1: API Stockpiling and U.S. Pharma Supply - Insights from PBOA’s Gil Roth

    On August 16, the administration issued an executive order to fill the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). The plan begins by stockpiling a six-month supply of 26 critical drugs, with the goal of expanding to a list of 86 essential medicines. What does this mean for pharmaceutical manufacturing, contract development and manufacturing organizations (CDMOs), and the broader drug supply chain? In this episode of BWS Dialogues, we sit down with Gil Roth, President of the Pharma & Biopharma Outsourcing Association (PBOA), to unpack the implications of this initiative. Gil shares insights and offers a candid look at the opportunities, challenges, and unintended consequences. We explore questions such as: How does this plan build on—and differ from—previous U.S. drug stockpiling efforts? What short- and long-term impacts could this initiative have on pharmaceutical manufacturing and the CDMO sector? How effective are other recent measures, like accelerated FDA plant approvals, the PreCheck program, and EQUIP-A-Pharma in supporting U.S.-based drug manufacturing? How would pharmaceutical tariffs affect innovators, generics companies, and CDMOs? What other factors need to be considered to make reshoring efforts work? Gil offers his perspectives on how these programs intersect, what gaps remain, and what it will take to build a more resilient pharmaceutical supply chain in the United States. Learn More & Connect! Visit brandwidthsolutions.com for more information about our services! Connect with our guest, Gil Roth: LinkedIn Connect with our podcast host, Laura Bush: LinkedIn

    34 min

About

BWS Dialogues is a podcast from Brandwidth Solutions that explores the business topics and challenges our clients face, the opportunities for growth, and how to deploy the art and science of marketing to drive business success. Each episode features conversations with top leaders and problem solvers who share real-world insights, strategies, and best practices. Whether you're navigating complexity or bridging the gap between strategy and results, BWS Dialogues delivers practical perspectives to navigate critical topics and tackle the challenges that matter the most.